Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 71335-2102

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 71335-2102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lisinopril)

Chemical structure diagram of lisinopril, one of the active ingredients in the Lisinopril and Hydrochlorothiazide combination tablet. The diagram shows the molecular composition and bonding typical of the lisinopril molecule.*

FDA Label Image

Chemical Structure (HCTZ)

Chemical structure of Lisinopril and Hydrochlorothiazide showing the molecular diagram of the combined active ingredients.*

FDA Label Image

Label (Lbl713352102)

Label for Lisinopril and Hydrochlorothiazide 10 mg/12.5 mg tablets by Bryant Ranch Prepack. The label states the tablets are white and round with imprint H150. It includes storage instructions to keep at room temperature 20°-25°C and warnings to keep out of reach of children. The label compares the product to Zestoretic 10/12.5 mg tablets by Zhejiang Huahai Pharmaceutical Co. The package contains 90 tablets and shows NDC 71335-21021.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.